Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T16:31:05.194Z.
Calculation as of: 2026-10-06T16:31:05.194Z.
Quote observation: 2026-10-06T16:30:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 92e82853ec35d591c91e1857ba5f245e9338475f566e1ab86be3b7c1b83139db
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Artiva Biotherapeutics, Inc.
Market Cap
$354.70M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$355.36M
EV/EBITDA Ratio
N/A
TTM Avg
40.38x
3Y Avg
40.38x
5Y Avg
40.38x
Market Cap
$353.30M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$349.40M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$359.33M
EV/EBITDA Ratio
N/A
TTM Avg
37.95x
3Y Avg
29.61x
5Y Avg
22.14x
Market Cap
$374.75M
EV/EBITDA Ratio
N/A
TTM Avg
682.46x
3Y Avg
682.46x
5Y Avg
682.46x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $354.70M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $355.36M | N/A | 40.38x | 40.38x | 40.38x |
| Relmada Therapeutics, Inc. (RLMD)vs › | $353.30M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $359.46M | N/A | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.40M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $359.33M | N/A | 37.95x | 29.61x | 22.14x |
| Embecta Corp. (EMBC)vs › | $359.53M | 5.40x | 4.73x | 7.57x | 7.31x |
| Opus Genetics, Inc. (IRD)vs › | $363.54M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $374.75M | N/A | 682.46x | 682.46x | 682.46x |
| Agenus Inc. (AGEN)vs › | $333.02M | 8.67x | 20.16x | 20.16x | 12.62x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
